Structured evidence table for Potassium Exercise Recovery Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Potassium Exercise Recovery Randomized Trial | Current sports nutrition guidelines recommend that nutrient intake should occur soon after exercise, with the first 2 to 4 h considered a key window for effective recovery [,,]. | 1 | Tunçil Elif (2026) | Beyond Recovery: Effects of Post-Exercise Milk and Milk-Based Beverages on Appetite Regulation and Energy Intake—A Systematic Review and Meta-Analysis |
| Potassium Exercise Recovery Randomized Trial | Evidence suggests that milk and milk-based beverages may provide similar, or in some cases potentially superior, recovery benefits compared with alternative recovery beverages. | 1 | Tunçil Elif (2026) | Beyond Recovery: Effects of Post-Exercise Milk and Milk-Based Beverages on Appetite Regulation and Energy Intake—A Systematic Review and Meta-Analysis |
| Potassium Exercise Recovery Randomized Trial | In this regard, some studies have reported reduced hunger, increased fullness, and/or lower subsequent energy intake following milk or milk-based beverages compared with isocaloric or non-caloric control beverages, whereas others have observed no significant differences across these outcomes [,,]. | 1 | Tunçil Elif (2026) | Beyond Recovery: Effects of Post-Exercise Milk and Milk-Based Beverages on Appetite Regulation and Energy Intake—A Systematic Review and Meta-Analysis |
| Potassium Exercise Recovery Randomized Trial | 1 2 3 4 5 6 2 4 The post-exercise period represents a critical window for optimizing recovery, facilitating physiological adaptation, and supporting subsequent performance []. | 1 | Tunçil Elif (2026) | Beyond Recovery: Effects of Post-Exercise Milk and Milk-Based Beverages on Appetite Regulation and Energy Intake—A Systematic Review and Meta-Analysis |
| Potassium Exercise Recovery Randomized Trial | 5 6 9 7 Organic dysfunction resulting from kidney failure and the accumulation of uremic toxins is associated with cardiovascular, musculoskeletal, inflammatory, endocrine, neurological and respiratory disorders, among others []. | 2 | Barbosa Ana Paula Oliveira (2026) | Acute effect of photobiomodulation therapy in quadriceps strength, fatigue and pain of patients with chronic kidney failure: a randomized, double-blind, placebo controlled crossover clinical trial |
| Potassium Exercise Recovery Randomized Trial | Patients with CKD have a protein synthesis imbalance caused by metabolic acidosis, resistance to insulin and insulin-like growth factor type 1 (IGF-1), hormonal changes, cytokines, mitochondrial respiratory chain dysfunction, inflammatory processes, diminished appetite and increased malnutrition [–]. | 2 | Barbosa Ana Paula Oliveira (2026) | Acute effect of photobiomodulation therapy in quadriceps strength, fatigue and pain of patients with chronic kidney failure: a randomized, double-blind, placebo controlled crossover clinical trial |
| Potassium Exercise Recovery Randomized Trial | 10 11 11 13 14 Sarcopenia is characterized by reduced muscle strength associated with decreased mass and/or reduced muscle function and affects approximately 20% of kidney patients undergoing HD []. | 2 | Barbosa Ana Paula Oliveira (2026) | Acute effect of photobiomodulation therapy in quadriceps strength, fatigue and pain of patients with chronic kidney failure: a randomized, double-blind, placebo controlled crossover clinical trial |
| Potassium Exercise Recovery Randomized Trial | 1 2 3 4 Chronic kidney disease (CKD) is a condition that affects the health of millions of people around the world, with an estimated global prevalence of 9.5% of the population []. | 2 | Barbosa Ana Paula Oliveira (2026) | Acute effect of photobiomodulation therapy in quadriceps strength, fatigue and pain of patients with chronic kidney failure: a randomized, double-blind, placebo controlled crossover clinical trial |
Source documents